Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Other Non-Current Assets of $988922.1 for Q4 2025, down 62.01% year-on-year from $2.6 million in Q4 2024, and down 58.27% on a QoQ basis from $2.4 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Other Non-Current Assets for 3 consecutive years, with $988922.1 the latest figure, recorded in Q4 2025.
- Quarterly Other Non-Current Assets fell 62.01% year-over-year to $988922.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $988922.1 (down 62.01% YoY) and the FY2025 annual result came in at $1.0 million, down 60.85% from the prior year.
- Other Non-Current Assets eased to $988922.1 in Q4 2025 per ZYBT's latest filing, from $2.4 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for ZYBT reached as high as $2.6 million in Q4 2024 and fell as low as $903323.6 in Q4 2023.
- A 3-year average of $1.7 million and a median of $1.7 million in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 188.16% — and 2025, when it plunged 62.01%.
- Year by year, Other Non-Current Assets stood at $903323.6 in 2023, then surged by 188.16% to $2.6 million in 2024, then sank by 62.01% to $988922.1 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $988922.1, $2.4 million, and $2.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 85.93 Mn | - | 988,922.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 988,922.10 |
| Jun 30, 2025 | 2.37 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 903,323.61 |